The involvement of DNA and histone methylation in the repression of IL-1β-induced MCP-1 production by hypoxia

Biochemical and Biophysical Research Communications

Volumn 414, Issue 1, 2011, Pages 252-258

  Aoi, Yoko ^a   Nakahama, Ken ichi ^a   Morita, Ikuo ^a   Safronova, Olga ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

DNA methylation; Histone methylation; Hypoxia; Inflammation; Monocyte chemoattractant protein 1 (MCP 1); Transcriptional repression

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; GENE REPRESSION; GENE SILENCING; HELA CELL; HISTONE METHYLATION; HUMAN; HUMAN CELL; HYPOXIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

CELL HYPOXIA; CHEMOKINE CCL2; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HELA CELLS; HISTONES; HUMANS; INTERLEUKIN-1BETA; METHYLATION; TRANSCRIPTION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 80054080817     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.066     Document Type: Article

References (32)

1. Eltzschig H.K., Carmeliet P. Hypoxia and inflammation. N. Engl. J. Med. 2011, 364:656-665.
2. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 2001, 93:266-276.
3. Safronova O., Morita I. Transcriptome remodeling in hypoxic inflammation. J. Dent. Res. 2010, 89:430-444.
4. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
5. Peterson C.L., Laniel M.A. Histones and histone modifications. Curr. Biol. 2004, 14:R546-R551.
6. Siegfried Z., Eden S., Mendelsohn M., Feng X., Tsuberi B.Z., Cedar H. DNA methylation represses transcription in vivo. Nat. Genet. 1999, 22:203-206.
7. Sansom O.J., Maddison K., Clarke A.R. Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer. Nat. Clin. Pract. Oncol. 2007, 4:305-315.
8. Chow J.C., Brown C.J. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell. Mol. Life Sci. 2003, 60:2586-2603.
9. Delaval K., Feil R. Epigenetic regulation of mammalian genomic imprinting. Curr. Opin. Genet. Dev. 2004, 14:188-195.
10. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 2009, 10:295-304.
11. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., Benes V., Jeltsch A., Gannon F., Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
12. Kim M.S., Kondo T., Takada I., Youn M.Y., Yamamoto Y., Takahashi S., Matsumoto T., Fujiyama S., Shirode Y., Yamaoka I., Kitagawa H., Takeyama K., Shibuya H., Ohtake F., Kato S. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461:1007-1012.
13. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
14. Johnson A.B., Denko N., Barton M.C. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat. Res. 2008, 640:174-179.
15. Safronova O., Nakahama K., Onodera M., Muneta T., Morita I. Effect of hypoxia on monocyte chemotactic protein-1 (MCP-1) gene expression induced by Interleukin-1beta in human synovial fibroblasts. Inflamm. Res. 2003, 52:480-486.
16. Safronova O., Pluemsampant S., Nakahama K., Morita I. Regulation of chemokine gene expression by hypoxia via cooperative activation of NF-kappaB and histone deacetylase. Int. J. Biochem. Cell Biol. 2009, 41:2270-2280.
17. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., Fukushima J., Kawamoto S., Ishigatsubo Y., Okubo T. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 1994, 153:2052-2063.
18. Bjornsson H.T., Fallin M.D., Feinberg A.P. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 2004, 20:350-358.
19. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat. Res. 2006, 600:46-57.
20. Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 2004, 4:143-153.
21. Huber L.C., Stanczyk J., Jungel A., Gay S. Epigenetics in inflammatory rheumatic diseases. Arthritis Rheum. 2007, 56:3523-3531.
22. Wierda R.J., Geutskens S.B., Jukema J.W., Quax P.H., van den Elsen P.H. Epigenetics in atherosclerosis and inflammation. J. Cell Mol. Med. 2010, 14:1225-1240.
23. Watson J.A., Watson C.J., McCrohan A.M., Woodfine K., Tosetto M., McDaid J., Gallagher E., Betts D., Baugh J., O'Sullivan J., Murrell A., Watson R.W., McCann A. Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum. Mol. Genet. 2009, 18:3594-3604.
24. Shahrzad S., Bertrand K., Minhas K., Coomber B.L. Induction of DNA hypomethylation by tumor hypoxia. Epigenetics 2007, 2:119-125.
25. Skowronski K., Dubey S., Rodenhiser D., Coomber B. Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells. Epigenetics 2010, 5:547-556.
26. Klose R.J., Sarraf S.A., Schmiedeberg L., McDermott S.M., Stancheva I., Bird A.P. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 2005, 19:667-678.
27. Yin H., Blanchard K.L. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms. Blood 2000, 95:111-119.
28. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., Black J.C., Hoffmann A., Carey M., Smale S.T. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138:114-128.
29. Nguyen C.T., Weisenberger D.J., Velicescu M., Gonzales F.A., Lin J.C., Liang G., Jones P.A. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res. 2002, 62:6456-6461.
30. Wada H., Kagoshima M., Ito K., Barnes P.J., Adcock I.M. 5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene. Biochem. Biophys. Res. Commun. 2005, 331:93-99.
31. Wang Z., Yang D., Zhang X., Li T., Li J., Tang Y., Le W. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS ONE 2011, 6:e19229.
32. Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007, 130:77-88.